Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

Jens Kuhle, Harald Kropshofer, Dieter A. Haering, Uma Kundu, Rolf Meinert, Christian Barro, Frank Dahlke, Davorka Tomic, David Leppert, Ludwig Kappos

Open source

DOI
10.1212/wnl.0000000000007032
Published
2019-03-05
Container
Neurology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000007032,
  title = {Blood neurofilament light chain as a biomarker of MS disease activity and treatment response},
  author = {Jens Kuhle and Harald Kropshofer and Dieter A. Haering and Uma Kundu and Rolf Meinert and Christian Barro and Frank Dahlke and Davorka Tomic and David Leppert and Ludwig Kappos},
  year = {2019},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000007032},
  url = {https://doi.org/10.1212/wnl.0000000000007032}
}

RIS

TY  - JOUR
TI  - Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
AU  - Jens Kuhle
AU  - Harald Kropshofer
AU  - Dieter A. Haering
AU  - Uma Kundu
AU  - Rolf Meinert
AU  - Christian Barro
AU  - Frank Dahlke
AU  - Davorka Tomic
AU  - David Leppert
AU  - Ludwig Kappos
PY  - 2019
JO  - Neurology
DO  - 10.1212/wnl.0000000000007032
UR  - https://doi.org/10.1212/wnl.0000000000007032
ER  - 

APA

Kuhle, J., Kropshofer, H., Haering, D. A., Kundu, U., Meinert, R., Barro, C., Dahlke, F., Tomic, D., Leppert, D., & Kappos, L. (2019). Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. https://doi.org/10.1212/wnl.0000000000007032

Source records